Eagles' DeVonta Smith A Contract Bargain As Receivers' Salaries Skyrocket
The Philadelphia Eagles have created a legacy in many ways, including for being an organization often willing to pay its young stars on the come.
Philadelphia's philosophy focuses on extending players before they have to, which can be a dice roll but can also allow them to remain flexible in building their roster with long-term saving of elbow room under the cap.
Extensions to stars like A.J. Brown and Jalen Hurts have allowed the Eagles to remain among the more dominant teams in the league.
Along the way, as time passes, those contracts – so eye-popping when initially announced – move from being massive and lucrative long-term commitments to being relative bargains.
That is, if the team is right about the player's star potential.
It's a game of "Keeping Up with the Joneses,'' in a sense; the NFL offseason always features the paying of the next great player a bit more than the highest-paid star the year before.
A great example of how this has worked for the Eagles comes not just from an All-Pro like Brown (making $32 million APY) but also from his running mate, DeVonta Smith.
Smith's current contract pales in comparison to the latest receiver to sign a long-term extension. New York Jets wideout Garrett Wilson signed a four-year extension Monday afternoon worth an average annual salary of $32.5 million.
Wilson became the fifth-highest-paid receiver in the game with his contract. And relative to his contract? The Eagles figure to be appreciative of Smith than ever better.
The Heisman Trophy winner Smith was a first-round pick by the team back in 2021 and has enjoyed the best start to a receiver in team history. He has recorded over 300 receptions with over 4,000 yards and 27 touchdowns. Following the 2023 season, Smith signed a three-year extension worth just $75 million.
The average annual salary of just $25 million may have been a milestone mark a few years ago, but that changed quickly in just the last calendar season. Suddenly, his contract ranks at just 13th in the league.
With Wilson's extension, the deal highlights some of the players now at his position who produce similar numbers but cost millions less.
Smith is that player for the Eagles.
This story was originally reported by Athlon Sports on Jul 15, 2025, where it first appeared.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Julio Rodríguez's second homer of the game (17)
Julio Rodríguez launches his second solo homer of the game to tie the game at 2 in the top of the 6th inning
Yahoo
8 minutes ago
- Yahoo
Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity
Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The company reported strong earnings in the second quarter of 2025. It posted revenue of $11.1 billion, which showed a 7.37% growth on a YoY basis. The company reported GAAP diluted earnings per share of $1.01, while adjusted diluted EPS came in at $1.26. Gross margin was 52.7% of sales on a reported basis, with the adjusted gross margin reaching 57.0%, representing a 100 basis point improvement. Abbott Laboratories (NYSE:ABT) reiterated its guidance and pointed to strong momentum in both its devices and nutrition segments as it moves into the second half of the year. A brief valuation analysis, based on a five-year free cash flow CAGR of 5.74%— calculated using 6% growth in operating cash flow and 2% growth in capital expenditures— suggests that the current share price of $120.51 offers promising return potential. On June 13, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 per share, which was in line with its previous dividend. This was the company's 406th consecutive quarterly dividend. In addition, ABT has raised its payouts for 53 years in a row. The stock offers a quarterly dividend of 1.86%, as of July 25. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
8 minutes ago
- Yahoo
Why Oversold Lockheed Martin (LMT) Could Be a Defensive Dividend Powerhouse
Lockheed Martin Corporation (NYSE:LMT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. Two fighter jets in flight, highlighting the technology and experience of the companies combat aircraft. The company has long held a leading position in the US aerospace and defense sector. It supplies advanced technologies and services to the US Department of Defense, NASA, and various international government agencies. Its space division is one of the company's four key segments. For investors looking for a diversified and established aerospace company with ties to the growing space industry, Lockheed Martin may be a strong addition to their portfolio. Lockheed Martin Corporation (NYSE:LMT) maintained a strong cash position, reinforcing its appeal as a reliable dividend investment. In the most recent quarter, the company reported an operating cash flow of $201 million. It also returned $1.3 billion to investors through dividends and share repurchases. On June 26, Lockheed Martin Corporation (NYSE:LMT) declared a quarterly dividend of $3.30 per share, which was consistent with its previous dividend. The company has been rewarding shareholders with growing dividends for the past 22 years. The stock offers a dividend yield of 3.11%, as of July 25. While we acknowledge the potential of LMT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.